Two core components of the PHIRE solution have been independently assessed at the European level, confirming their strong innovation and market potential. The urine-stable targeted gold nanorods,
Article published by Euro-BioImaging on 21 July 2025. Read the full article here. Bladder cancer affects hundreds of thousands of people every year, and many patients experience
Bladder cancer surgery follows well-established clinical guidelines. Yet recurrence remains frequent. Even after tumour removal, microscopic residual disease, often smaller than one millimetre, can remain undetected. How can we detect tumour areas that current surgical tools cannot visualise?
Date: 16 June 2026 Time: 2-3:10 PM CEST REGISTER HERE On 16 June 2026, PHIRE team is organising an online panel discussion, where the experts will share
